v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2021 $ 767,557 $ (43,693) $ 196,383 $ 59,668 $ (59,668) $ (2,228) $ 513,734 $ 15,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 112,673           112,673  
Dividends declared (7,684)           (7,684)  
Other comprehensive income (loss), net of tax 786         786    
Stock repurchases under buyback program (24,779)   (3,062)       (21,717)  
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (9,999)   (9,999)          
Stock-based compensation expense 5,111   5,111          
Ending balance at Mar. 27, 2022 799,972   188,433 0   (1,442) 612,981  
Beginning balance at Dec. 31, 2022 955,169   197,003 0   (695) 758,861  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 30,173           30,173  
Dividends declared (10,086)           (10,086)  
Other comprehensive income (loss), net of tax (9)         (9)    
Stock repurchases under buyback program (3,660)   (485)       (3,175)  
Repurchases of shares for tax payments related to the vesting and exercising of share-based grants (7,499)   (7,499)          
Issuance of shares upon exercise of common stock options 492   492          
Stock-based compensation expense 5,242   5,242          
Ending balance at Apr. 02, 2023 $ 969,822   $ 194,753 $ 0   $ (704) $ 775,773